A carregar...

Response and survival in advanced breast cancer after two non-cross-resistant combinations.

A prospective study with two cytotoxic combinations (cyclophosphamide, methotrexate, and fluorouracil (CMF), and adriamycin plus vincristine (AV)) was carried out in 110 patients with advanced breast cancer. There was no significant difference between the treatment groups in the response rate after...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brambilla, C, De Lena, M, Rossi, A, Valagussa, P, Bonadonna, G
Formato: Artigo
Idioma:Inglês
Publicado em: 1976
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1639498/
https://ncbi.nlm.nih.gov/pubmed/1260337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!